Men with a pathogenic BRCA1 variant exhibit a mildly elevated lifetime breast cancer risk of approximately 1%, while those with a pathogenic BRCA2 variant have a lifetime risk of around 8% [17, 18]. This evidence concerns the gene BRCA1 and breast cancer.